“…Interestingly, a reduction in PGRN expression has been observed in an acute kidney injury mouse model after ischemia/reperfusion and in the cerebrospinal fluid of patients with subarachnoid hemorrhage (Zhou, Tang, et al, ; Zhou, Xie, et al, ), suggesting that PGRN expression in inflammatory disorders may be, in part, dependent on the particular disease model. In pulmonary inflammatory diseases, PGRN overexpression is also apparent in the lung tissues of a mouse endotoxic shock model (Yu et al, ), in the sera of patients with sepsis (Song et al, ), and in the BALF from patients with community‐acquired pneumonia (Zou et al, ). However, the levels of PGRN in the BALF are decreased in mice on day three after induction with of ALI by intraperitoneal injection of LPS (Guo et al, ).…”